Calder Biosciences

Vaccines · Biotechnology

Overview

Calder Biosciences is a nano-scale molecular engineering company developing next generation best-in-class conformationally-stabilized Universal Influenza and RSV recombinant subunit vaccines.

Funding and backers

Team
51-200
employees, estimated range
Grants
$6.7M
4 grants · CORDIS
Backers
1
SOSV
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Feb 15, 2020 Won a grant $2.9M · CORDIS May 15, 2019 Won a grant $300k · CORDIS Jul 5, 2018 Won a grant $600k · CORDIS Jan 10, 2018 Won a grant $2.9M · CORDIS
Tractionpublic signals, read monthly
Web presence
top 6%
of 133.2M domains by links, Common Crawl
Funding rounds
RoundDateAmountInvestorsSource
Grant Feb 2020 $2.9M — CORDIS
Grant May 2019 $300k — CORDIS
Grant Jul 2018 $600k — CORDIS
Grant Jan 2018 $2.9M — CORDIS
Backed byfrom the funds' portfolios and accelerator catalogs
SOSV accelerator
Investors in similar startupsfunds that back the companies most like this one
OrbiMed
backs Curevo Vaccine, 2024 Epigenic Therapeutics, Inc.
SFC Capital
backs ReNewVax logo
RA Capital Management
backs GIVAX
IQ Capital
backs Base Immune
Qiming Venture Partners
backs 2024 Epigenic Therapeutics, Inc.
Hoxton Ventures
backs Base Immune
Similar startupsby what they do, their industry and backers
ReNewVax logoVenture round · 10 mo ago · Founded 2022
Protecting Our Future. ReNewVax is a next-generation bacterial vaccine company developing the first universal vaccine targeting all ca.100…
Curevo Vaccine51-200 employees
Curevo Vaccine is a clinical-stage biotech company dedicated to developing next-generation adjuvanted subunit vaccines to the market…
2024 Epigenic Therapeutics, Inc.Founded 2021
Epigenic Therapeutics is a frontier biotechnology company dedicated to developing next generation gene modulation therapy utilizing…
Hexamer TherapeuticsVenture round $500k · 4 mo ago · 1-10 employees
Innovators in natural vaccine technology. Explore rapidly engineered, scalable vaccine technologies at Hexamer Therapeutics.
Thyreos Vaccines1-10 employees
Thyreos develops herpesvirus vaccines and vaccine vectors for the animal health and human health markets. Thyreos vaccines are based on a…
GIVAX51-200 employees
GIVAX is developing a new class of vaccines to protect children from severe gastroenteritis caused by rotavirus and norovirus. Leveraging…

Visa sponsorship

United StatesUS 0
0
H-1B filings in 12 months
1
Green card filings
$123k
Median offered salary
In the register as CALDER BIOSCIENCES INC., Brooklyn, NY (+1 more)
Other sponsors in the same field
Terrestrial 4 filingsVersatope Therapeutics 2 filingsEpiVaxModerna 101 filings
Alert me
US Department of Labor · latest filing Aug 14, 2025 · Visa details by country

Financials

Total raised
$6.7M
Latest round
Grant
Funding rounds
4
Funding rounds
Round Announced Amount
Grant 2020 $2.9M Details
Grant 2019 $300k Details
Grant 2018 $600k Details
Grant 2018 $2.9M Details

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
SOSVVia a fund
777 portfolio companies
Report a mistake

Offices

Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Brooklyn United States
HQ
Calder Biosciences
140 58th Street, Bldg A, Unit 8J, Brooklyn, NY 11220
company site
New York United States
HQ
Book Zoom via Calendly [email protected] +1-917-806-4057 Calder Deck PDF
7 Penn Plaza, 9th Fl, New York, NY 10001
company site